|
ZBTB44 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.04639999998213E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.79449999304637E-09 |
| Normal-vs-Stage2 |
6.967700E-02 |
| Normal-vs-Stage3 |
7.180900E-04 |
| Normal-vs-Stage4 |
2.42739999999353E-05 |
| Stage1-vs-Stage2 |
9.833600E-02 |
| Stage1-vs-Stage3 |
5.753000E-01 |
| Stage1-vs-Stage4 |
6.212600E-01 |
| Stage2-vs-Stage3 |
3.848400E-01 |
| Stage2-vs-Stage4 |
1.824040E-01 |
| Stage3-vs-Stage4 |
4.528600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.99100000112196E-09 |
| Normal-vs-AfricanAmerican |
1.58185999999949E-05 |
| Normal-vs-Asian |
9.804100E-02 |
| Caucasian-vs-AfricanAmerican |
6.092000E-01 |
| Caucasian-vs-Asian |
8.478600E-01 |
| AfricanAmerican-vs-Asian |
7.144400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00450003870378E-09 |
| Normal-vs-Female |
1.301620E-03 |
| Male-vs-Female |
3.394100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.81929999965425E-07 |
| Normal-vs-Extreme_Weight |
2.54550003297993E-09 |
| Normal-vs-Obese |
8.235800E-04 |
| Normal-vs-Extreme_Obese |
1.795820E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.575600E-01 |
| Normal_Weight-vs-Obese |
9.714000E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.924600E-01 |
| Extreme_Weight-vs-Obese |
2.492400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.528000E-01 |
| Obese-vs-Extreme_Obese |
3.391000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.656800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.95290000002147E-06 |
| Normal-vs-Age(61-80Yrs) |
3.15619974600168E-10 |
| Normal-vs-Age(81-100Yrs) |
1.55879999996777E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.397000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.726070E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.773800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.859520E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.100220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.121800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.23010000027979E-07 |
| Normal-VS-Type2 PRCC |
3.73809871945241E-11 |
| Normal-VS-KIRP CIMP |
5.853800E-01 |
| Normal-VS-Unclassified PRCC |
1.106220E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.240800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.478570E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.021000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.408200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.234100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.084800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.49039996694734E-09 |
| Normal-vs-N1 |
1.148280E-02 |
| Normal-vs-N2 |
2.47230000000043E-05 |
| N0-vs-N1 |
1.255350E-01 |
| N0-vs-N2 |
8.600000E-02 |
| N1-vs-N2 |
6.472400E-02 |
|
|
